Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Postoperative Tranexamic Acid Use in Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial

NCT05099276 is registered in ClinicalTrials.gov with Campbell Clinic as lead sponsor.

NCT NCT05099276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05099276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Postoperative Tranexamic Acid Use in Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial
Lead sponsor
Campbell Clinic
Phase
Phase 4
Overall status
Unknown status
Start date
December 7, 2021
Completion date
June 1, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, knee osteoarthritis, pain, postoperative